Item Type: | Article |
---|---|
Title: | Prognoserelevanz von biologischen und molekularen Markern in der Onkologie : Kriterien fur Studienplanung und -Interpretation. [Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies] |
Creators Name: | Bollschweiler, E., Schneider, P.M., Moenig, S.P., Altendorf-Hofmann, A., Mansmann, U., Lehmacher, W., Schlag, P.M., Merkel, S., Hohenberger, W., Izbicki, J.R., Hermanek, P. and Hoelscher, A.H. |
Abstract: | Experts on different specialities (surgery, pathology, molecular biology and medical statistics) discussed the evaluation of prognostic factors during a workshop. The most important results presented are: (1) the prognostic relevance of new biological or molecular markers must be evaluated in a phase-III prognostic study. To establish such a marker in the UICC-TNM-classification in at least two different centers, two multivariate analyses according to defined criteria are necessary; (2) the standards of laboratory methods have to be defined, e.g.,which method to apply for RNA-analysis, which materials to used, etc; (3) intensive data analysis should be done before using methods of multivariate analysis. The criteria for the presentation of survival curves are given in detail; (4) in multivariate analysis, the Cox proportional hazard regression for survival outcomes is discussed with explanations and examples of the terms relative risk, odds-ratio, hazard and relative hazard. The arrangement and interpretation of a good prognostic study should be performed as an interdisciplinary approach. |
Keywords: | Prognosis, Biological Marker, Molecular Marker, TNM-Classification, Univariate Analysis, Multivariate Analysis |
Source: | Chirurg |
ISSN: | 0009-4722 |
Publisher: | Springer |
Volume: | 74 |
Number: | 2 |
Page Range: | 139-144 |
Date: | February 2003 |
Official Publication: | https://doi.org/10.1007/s00104-002-0557-7 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page